Frank Spangler brings an impressive 25+ years of experience in clinical testing, medical device manufacturing, forensic validation services, research & development, and instrument design to Doc Lab Inc. His extensive background includes management and directorship roles in new clinical test development, FDA clearance processes, clinical laboratory operations, business planning, and new diagnostic equipment design and validation.

Frank’s proven track record of success is evident in the numerous accomplishments throughout his career, including designing and establishing several clinical laboratories, bringing 18 different molecular diagnostic assays to market, and working in both CLIA and ISO 13485 environments. His experience spans a variety of leadership roles, from Chief Executive Officer at Redstone Biotechnologies to Chief Operations Officer at SoftCell Biological Research, Director of Molecular Development at DxNA, and various other prestigious positions.

Notably, Frank has developed an extensive range of diagnostic tests, demonstrating his commitment to innovation and excellence in the field. His expertise and dedication to advancing healthcare make him an invaluable asset to the Doc Lab Inc team as they continue to revolutionize point-of-care diagnostics.